Back

The RESPONDER trial: A feasibility study of an early intervention model deploying community first responders to administer intranasal naloxone in suspected opioid overdoses

2025-12-21 addiction medicine Title + abstract only
View on medRxiv
Show abstract

IntroductionOpioid use continues to cause harm and fatalities worldwide, despite ongoing preventive efforts. Early administration of the antidote naloxone can reverse potentially fatal opioid overdoses. Naloxone distribution programs have increased survival across regions; however, additional efforts are needed to reduce opioid overdose mortality. One approach is to expand naloxone availability within communities. Methods and analysisThe feasibility trial RESPONDER (REgion Sk[a]ne Preventing Ov...

Predicted journal destinations